Earlier episodes
The conversation so far
Oura’s Ricky Bloomfield, Gyde’s Will Johnson, Parkinson’s Cell Therapy, Blue Cross SuedRicky Bloomfield, Oura · Will Johnson, Gyde
Tanay Tandon on Agents in RCM, Nikhil Krishnan, and Fat Cells That RememberNikhil Krishnan, Out-of-Pocket · Tanay Tandon, Commure
Oura Delays Its IPO, Did AI Add $1B to Healthcare?Caroline Zhang, Knowtex · Julie Yoo, a16z · Tim Wike, Coupe Health
GLP-1 race, Crémieux on embryo selection, and corporate control of medical practicesJordan Lasker, Cremieux · Otto Sipe, Photon
Oura Going Public / Muscle Drugs / Medicare Gold Rush Over / Apple Wants to Be Your Health HomeScott Law, Meridian Street Capital · Stuart Blitz, Hone Health
Healthcare Costs Jump 11%, AI Drug Reverses Aging? America Is Losing the Clinical Trial RaceArthur MacWaters, Legion Health
Epic Probed by the FTC, Trump's MFN Drug Pricing, Healthcare M&A FeverBrendan Keeler, HTD Health · Marshall Jackson Jr., McDermott Will & Schulte
Neal Khosla on AI Doctors, Cancer Vaccines, Alliant + Nava, Food ContaminationBrandon Weber, Nava Benefits · Kevin Overbey, Alliant Benefits · Neal Khosla, Curai Health
Can Doctors Make AI Worse? Psychedelics Go Mainstream, Calley Means & CrémieuxJordan Lasker, Cremieux · Calley Means, U.S. Department of Health and Human Services
Human Organ Data Centers, GLP-1 for Sleep, Rural Hospitals in CrisisAndrei Georgescu, Vivodyne · Gurdane Bhutani, Vivodyne · Mike Kopko, Pearl Health
The Future of Healthcare: Peptides, GLP-1 Disruption, ICHRA & CMS AIAri Gottlieb, A2 Strategy · Chris Ellis, Thatch · Jacob Shiff, CMS Innovation Center · Kyle Faget, McDermott Will & Schulte
HCN is commentary and entertainment, not medical, legal, or financial advice. Views are the speakers’ own.